Tredegar Stock

Tredegar ROE

The Return on Equity (ROE) of Tredegar (TG) as of Aug 12, 2026 is 15.46 %. In the previous year, Return on Equity (ROE) was -35.68 % — a change of -143.33% (higher).

ROE

15.46 %

YoY

-143.33%

Last updated:

In 2026, Tredegar's return on equity (ROE) was 15.46 %, a -143.33% increase from the -35.68 % ROE in the previous year.

Access this data via the Eulerpool API

Tredegar Stock analysis

What does Tredegar do? Tredegar Corporation is a multinational corporation based in the USA that operates in various business sectors. The company was founded in 1988 through the merger of Tredegar Industries and Crown Cork International. The company is divided into three main business segments: Plastic Films, Aluminum Extrusions, and Healthcare. Within these segments, Tredegar offers a wide range of products and services for various applications. The Plastic Films product line of Tredegar Corporation includes plastic films used in a variety of applications, including packaging films for food and medical devices, as well as films for the construction, electronics, and automotive industries. Tredegar also produces specialty films for applications that require high chemical resistance or high temperature resistance. Tredegar's Aluminum Extrusions division manufactures aluminum profiles for a variety of applications, including window and door frames, ships, trucks and trailers, as well as solar power systems. They also produce foamed aluminum products that are lightweight yet durable, making them suitable for use in the automotive and construction industries. Tredegar is also active in the healthcare sector and operates a subsidiary called "Nile Therapeutics." Nile develops and markets innovative drug-based therapies for cardiovascular diseases. The company has conducted several clinical trials and is currently in the late stage of developing a new drug called "Cenderitide" for the treatment of acute heart failure. As a global company, Tredegar achieved sales of approximately $1.1 billion in 2020. The company is listed on the New York Stock Exchange and employs around 3,000 employees. Tredegar's products are used in various industries worldwide, and the company has production facilities in North America, Europe, and Asia. Despite already having a wide range of products, the company is constantly making efforts to further develop and diversify its products. Recently, Tredegar announced its entry into the market for medical extrusion components to further expand its healthcare business. Overall, Tredegar is a versatile and expanding company operating in different business sectors and offering a wide range of products. Its strategic focus on innovation and diversification will allow the company to solidify its position globally and generate future growth. Tredegar is one of the most popular companies on Eulerpool.

ROE Details

Decoding Tredegar's Return on Equity (ROE)

Tredegar's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Tredegar's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Tredegar's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Tredegar’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Tredegar stock

Return on Equity (ROE) of Tredegar is 15.46 % in 2026.

Return on Equity (ROE) of Tredegar changed from -35.68 % to 15.46 %, representing a -143.33% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Tredegar since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Tredegar with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

Profitability — Tredegar

All Key Metrics — Tredegar